Octapharma AG - R&D Plasma 
EN: Navigation mit Access Keys
- [Alt + 0] - Startseite
- [Alt + 1] - Navigation
- [Alt + 2] - Inhalt
- [Alt + 3] - Kontakt
- [Alt + 4] - Sitemap
- [Alt + 5] - Suche
Develops nonvel Plasma-derived Therapeutic Protein Products
EN: Hauptnavigation
We are always looking for new plasma proteins to extend therapeutic indications and to improve treatments.
R&D Plasma
Octapharma’s R&D Plasma Group:
- Supports life-cycle management (LCM) activities for the product portfolio, focusing on key regulatory, production and marketing areas.
- Develops novel plasma-derived therapeutic protein products.
The Group includes 3 centres of excellence working closely together: